Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Wolff

Showing results (51-60 of 123) with videos related to

Pageof 13
Sort By:
Pharmacoeconomics|May 2, 2023
Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology AppraisalWillem Witlox, Sabine Grimm, Jeremy Howick, et al.
The Cochrane Database of Systematic Reviews|January 28, 2021
Electrocoagulation for liver metastasesDawid Storman, Mateusz J Swierz, Robert P Riemsma, et al.
The Cochrane Database of Systematic Reviews|July 11, 2019
Cryotherapy for liver metastasesMalgorzata M Bala, Robert P Riemsma, Robert Wolff, et al.
The Oncologist|December 21, 2017
Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of VaterPat Gulhati, Kanwal Raghav, Rachna Shroff, et al.
Journal of Clinical Medicine|September 10, 2021
Challenges and Controversies in the Surgical Treatment of Cervical Cancer: Open Radical Hysterectomy versus Minimally Invasive Radical HysterectomyJona Röseler, Robert Wolff, Dirk O Bauerschlag, et al.
Pharmacoeconomics|February 28, 2026
Accounting for Genomic Testing Costs in Cost-Effectiveness Evaluations: Challenges and Lessons Learned from the NICE Single Technology Appraisal of Erdafitinib for Treating Unresectable or Metastatic Urothelial Cancer with FGFR3 Alterations After a PD-1 or PD-L1 InhibitorAndrea Fernández Coves, Mirre Scholte, Jonathan Emerson, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Pulmonary Resection after Radiosurgery and Neoadjuvant Immunochemotherapy for NSCLC Patients with Synchronous Brain Metastasis-A Case Series of Three PatientsAgnes Koch, Stefan Sponholz, Stephan Trainer, et al.
Journal of Neurosurgery|January 1, 2003
Experimentally determined three-dimensional dose distributions in small complex targetsAndreas Mack, Robert Wolff, Dirk Weltz, et al.
Journal of Neurosurgical Sciences|February 8, 2020
Postoperative stereotactic radiosurgery and hypofractionated radiotherapy for brain metastases using Gamma Knife and CyberKnife: a dual-center analysisJens Kübler, Michael Wester-Ebbinghaus, Frederik Wenz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2022
Duration of Protection After Vaccination Against Yellow Fever: A Systematic Review and Meta-AnalysisKerstin Kling, Cristina Domingo, Christian Bogdan, et al.
Pageof 13

Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Pharmacoeconomics|May 2, 2023
Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology AppraisalWillem Witlox, Sabine Grimm, Jeremy Howick, et al.
The Cochrane Database of Systematic Reviews|January 28, 2021
Electrocoagulation for liver metastasesDawid Storman, Mateusz J Swierz, Robert P Riemsma, et al.
The Cochrane Database of Systematic Reviews|July 11, 2019
Cryotherapy for liver metastasesMalgorzata M Bala, Robert P Riemsma, Robert Wolff, et al.
The Oncologist|December 21, 2017
Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of VaterPat Gulhati, Kanwal Raghav, Rachna Shroff, et al.
Journal of Clinical Medicine|September 10, 2021
Challenges and Controversies in the Surgical Treatment of Cervical Cancer: Open Radical Hysterectomy versus Minimally Invasive Radical HysterectomyJona Röseler, Robert Wolff, Dirk O Bauerschlag, et al.
Pharmacoeconomics|February 28, 2026
Accounting for Genomic Testing Costs in Cost-Effectiveness Evaluations: Challenges and Lessons Learned from the NICE Single Technology Appraisal of Erdafitinib for Treating Unresectable or Metastatic Urothelial Cancer with FGFR3 Alterations After a PD-1 or PD-L1 InhibitorAndrea Fernández Coves, Mirre Scholte, Jonathan Emerson, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Pulmonary Resection after Radiosurgery and Neoadjuvant Immunochemotherapy for NSCLC Patients with Synchronous Brain Metastasis-A Case Series of Three PatientsAgnes Koch, Stefan Sponholz, Stephan Trainer, et al.
Journal of Neurosurgery|January 1, 2003
Experimentally determined three-dimensional dose distributions in small complex targetsAndreas Mack, Robert Wolff, Dirk Weltz, et al.
Journal of Neurosurgical Sciences|February 8, 2020
Postoperative stereotactic radiosurgery and hypofractionated radiotherapy for brain metastases using Gamma Knife and CyberKnife: a dual-center analysisJens Kübler, Michael Wester-Ebbinghaus, Frederik Wenz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2022
Duration of Protection After Vaccination Against Yellow Fever: A Systematic Review and Meta-AnalysisKerstin Kling, Cristina Domingo, Christian Bogdan, et al.
Pageof 13